Colonial Trust Advisors’s Editas Medicine EDIT Stock Holding History

Colonial Trust Advisors’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$74	Hold	30	–	–	﹤0.01%	710
2025 Q4	$62	Hold	30	–	–	﹤0.01%	687
2025 Q3	$104	Hold	30	–	–	﹤0.01%	672
2025 Q2	$66	Hold	30	–	–	﹤0.01%	687
2025 Q1	$35	Hold	30	–	–	﹤0.01%	669
2024 Q4	$38	Hold	30	–	–	﹤0.01%	671
2024 Q3	$102	Hold	30	–	–	﹤0.01%	737
2024 Q2	$140	Hold	30	–	–	﹤0.01%	740
2024 Q1	$223	Hold	30	–	–	﹤0.01%	970
2023 Q4	$304	Hold	30	–	–	﹤0.01%	845
2023 Q3	$234	Hold	30	–	–	﹤0.01%	864
2023 Q2	$247	Hold	30	–	–	﹤0.01%	866
2023 Q1	$218	Hold	30	–	–	﹤0.01%	860
2022 Q4	$266	Buy	+30	New	+$329	﹤0.01%	858

Other funds holding EDIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Colonial Trust Advisors's EDIT Position: Q1 2026 in Review

Colonial Trust Advisors held its Editas Medicine (EDIT) position steady in Q1 2026 at 30 shares worth $74. The position accounts for ﹤0.01% of the portfolio, ranked #710.

Colonial Trust Advisors first reported a position in EDIT in Q4 2022 and has held it in 14 quarters since. The position peaked at $304 in Q4 2023. 207 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

Colonial Trust Advisors held 30 shares of Editas Medicine worth $74 as of Q1 2026.
Colonial Trust Advisors left its Editas Medicine share count unchanged in Q1 2026.
Editas Medicine made up ﹤0.01% of Colonial Trust Advisors's portfolio in Q1 2026, its #710 holding.
Colonial Trust Advisors first reported a position in Editas Medicine in Q4 2022 and has held it in 14 quarters since.
Colonial Trust Advisors's Editas Medicine position peaked at $304 in Q4 2023.
207 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Colonial Trust Advisors's 13F filing for Q1 2026, filed 12 May 2026.